The protective effect of AST on CVB3-induced viral myocarditis

liu tianlong,liu xiaoling,zhang yong,niu haiyan,xiao yunfeng,liu xiaolei
DOI: https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2018.20.03
2018-01-01
Abstract:OBJECTIVE To study the protective effect and mechanism of Astragalus saponins(AST)against viral myocarditis in mice.METHODS CVB3,cardiomyocytes and BALB/C mice were used to prepare mouse model of viral myocarditis,which was then treated with AST.The protective effects of AST were evaluated by survival,the ratio of heart to body weight,echocardiographic assessment,the extent of myocardial fibrosis,and the expression of LDH and CK-MB in peripheral blood.Cell viability,apoptosis and the mRNA expression of Caspase-3 and Fas were detected to evaluate the protective mechanism of AST on CVB3-induced myocarditis.RESULTS AST could significantly increase survival and decrease the ratio of heart to body weight.Myocardial fibrosis level in the AST group was significantly lower than that in the CVB3 group.Compared with the CVB3 group,the ejection fraction was increased significantly in the AST group.Levels of LDH and CK-MB in the heart were significantly lower in heart of AST treatment than those in the CVB3-induced heart.In vitro,AST could significantly decrease CVB3-induced primary cardiomyocytes apoptosis.Expressions of Caspase-3 and Fas in the AST group were significantly lower than those in the CVB3 group.CONCLUSION AST has a protective effect against CVB3-induced viral myocarditis,which may be associated with a decrease in CVB3-induced apoptosis and down-regulation of expression of Caspase-3 and Fas.
What problem does this paper attempt to address?